Trials / Conditions / Unresectable Cutaneous Melanoma
Unresectable Cutaneous Melanoma
6 registered clinical trials studyying Unresectable Cutaneous Melanoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial NCT07155317 | Emory University | Phase 2 |
| Recruiting | Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected NCT06265285 | Mayo Clinic | Phase 2 |
| Withdrawn | A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metas NCT05572463 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 / Phase 2 |
| Recruiting | Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positiv NCT05098210 | Fred Hutchinson Cancer Center | Phase 1 |
| Terminated | Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype NCT04375527 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Completed | Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melano NCT03033576 | National Cancer Institute (NCI) | Phase 2 |